EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Nomogram for Predicting Cancer‐Specific Survival in Young Patients With Advanced Lung Cancer Based on Competing Risk Model

Jiaxin Li, Bolin Pan, Qiying Huang, Chulan Zhan, Tong Lin, Yangzhi Qiu, Honglang Zhang, Xiaohong Xie, Xinqin Lin, Ming Liu, Liqiang Wang, Chengzhi Zhou iD

The Clinical Respiratory Journal · 2024

DOI: 10.1111/crj.13800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2024. Verfasst von Jiaxin Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Nomograms, SEER Program, Neoplasm Staging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Innovation Project of Guangzhou Medical University, Wu Jieping Medical Foundation, State Key Laboratory of Respiratory Disease-The Independent project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Young lung cancer is a rare subgroup accounting for 5% of lung cancer. The aim of this study was to compare the causes of death (COD) among lung cancer patients of different age groups and construct a nomogram to predict cancer‐specific survival (CSS) in young patients with advanced stage.

Methods

Lung cancer patients diagnosed between 2004 and 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database and stratified into the young (18–45 years) and old (> 45 years) groups to compare their COD. Young patients diagnosed with advanced stage (IVa and IVb) from 2010 to 2015 were reselected and divided into training and validation cohorts (7:3). Independent prognostic factors were identified through the Fine‐Gray's test and further integrated to the competing risk model. The area under the receiver operating characteristic curve (AUC), consistency index (C‐index), and calibration curve were applied for validation.

Results

The proportion of cancer‐specific death (CSD) in young patients was higher than that in old patients with early‐stage lung cancer ( p < 0.001), while there was no difference in the advanced stage ( p = 0.999). Through univariate and multivariate analysis, 10 variables were identified as independent prognostic factors for CSS. The AUC of the 1‐, 3‐, and 5‐year prediction of CSS was 0.688, 0.706, and 0.791 in the training cohort and 0.747, 0.752, and 0.719 in the validation cohort. The calibration curves demonstrated great accuracy. The C‐index of the competing risk model was 0.692 (95% CI: 0.636–0.747) in the young patient cohort.

Conclusion

Young lung cancer is a distinct entity with a different spectrum of competing risk events. The construction of our nomogram can provide new insights into the management of young patients with lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsNomogramsSEER ProgramNeoplasm StagingHumansMaleFemaleMiddle AgedAdultPrognosisRisk AssessmentAdolescentYoung AdultAge FactorsSurvival RateROC CurveAgedRisk FactorsRetrospective StudiesCause of Death

Stichwörter der Autor:innen

competing risk modelnomogramyoung lung cancer

Autor:innen und Institutionen

  • Department of Clinical Medicine, Guangzhou Medical University, Guangzhou, China.
  • Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, China.
  • College of Life Science, Henan University, Kaifeng, China.
  • Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory D…

ORCID-Profile: Chengzhi Zhou

Förderung

  • Science and Technology Innovation Project of Guangzhou Medical University
  • Wu Jieping Medical Foundation
  • State Key Laboratory of Respiratory Disease-The Independent project
  • Guangzhou Science and Technology Major Clinical Project

Zitieren

APA

Li, J., Pan, B., Huang, Q., Zhan, C., Lin, T., Qiu, Y., Zhang, H., Xie, X., Lin, X., Liu, M., Wang, L., & Zhou, C. (2024). A Nomogram for Predicting Cancer‐Specific Survival in Young Patients With Advanced Lung Cancer Based on Competing Risk Model. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.13800

Vancouver

Li J, Pan B, Huang Q, Zhan C, Lin T, Qiu Y, et al. A Nomogram for Predicting Cancer‐Specific Survival in Young Patients With Advanced Lung Cancer Based on Competing Risk Model. The Clinical Respiratory Journal. 2024. doi:10.1111/crj.13800

BibTeX
@article{Li2024,
  author = {Li, Jiaxin and Pan, Bolin and Huang, Qiying and Zhan, Chulan and Lin, Tong and Qiu, Yangzhi and Zhang, Honglang and Xie, Xiaohong and Lin, Xinqin and Liu, Ming and Wang, Liqiang and Zhou, Chengzhi},
  title = {A Nomogram for Predicting Cancer‐Specific Survival in Young Patients With Advanced Lung Cancer Based on Competing Risk Model},
  journal = {The Clinical Respiratory Journal},
  year = {2024},
  doi = {10.1111/crj.13800}
}
Kostenlos starten →